Research & Discovery
Unique Schwann Cells: The Eyes Have It
UConn Health neuroscience researchers are finding genetic properties of what are known as Schwann cells in the cornea that may hold the key to breakthroughs in sensory function, healing, and even regeneration.
November 20, 2020 | Chris DeFrancesco '94 (CLAS)
Support for the Palmer Fellowship Impacts Pharmacy Practice Nationally
2020 marks the 20th anniversary of Dr. Henry (Hank) Palmer’s retirement from UConn. It is also Palmer’s 55th and 60th reunion year (’60 ‘65). Dr. Palmer was a beloved and much respected 42 year School of Pharmacy professor who passed away in 2009 but names the region’s annual Henry A. Palmer Continuing Education Finale (since […]
November 19, 2020 | Marie Smith, and Karin Whiting Burgess
Science Communication Course Teaches Skills for Modern Work Environment
A set of courses aim to help scientists-in-training better communicate their ideas to the public - and to help aspiring journalists learn more about science.
November 18, 2020 | Anna Zarra Aldrich '20 (CLAS), Office of the Vice President for Research
UConn Researchers Leveraging CT Health Data to Develop Suicide Risk Algorithms
UConn researchers are using multiple health care data sources for a project that could help health care providers better identify when patients are at risk of attempting suicide.
November 17, 2020 | Anna Zarra Aldrich '20 (CLAS), Office of the Vice President for Research
Pediatric Brain Cancer Research Reveals Potential for New Therapies
“We are all very excited about this finding,” says Dr. Ching Lau of UConn Health/JAX and Connecticut Children’s. “The take home message of these findings is that the fusion protein is altering the behavior of the tumor cells by dictating the genes that will be turned on and off. This gives us a better handle on which aberrantly expressed genes to target in developing novel therapeutics against supratentorial ependymoma.”
November 16, 2020 | Mark Wanner, The Jackson Laboratory
UConn Researcher Investigates Promising Candidate for Mitochondrial Disease Treatment
Researchers and clinicians are exploring many potential medicinal approaches for investigating and treating the root causes of diseases including gene and enzyme replacement therapy. But another therapeutic approach is to develop compounds that maintain cells in a healthy state. Cellular organelles called mitochondria are increasingly recognized as promising targets for such compounds. Mitochondria are responsible […]
November 16, 2020 | Anna Zarra Aldrich '20 (CLAS), Office of the Vice President for Research
Pancreatic Cancer Takes the Lives of Beloved U.S. Icons
Alex Trebek and U.S. Supreme Court Justice Ruth Bader Ginsberg brought awareness to the disease that is the 3rd leading cause of cancer-related deaths in the U.S. that has a 5-year survival rate of 10%.
November 12, 2020 | Jennifer Walker
Four UConn Researchers Named Women of Innovation by CT Tech Council
Four UConn researchers have been honored as Women of Innovation by the Connecticut Technology Council.
November 12, 2020 | Anna Zarra Aldrich '20 (CLAS), Office of the Vice President for Research
UConn Researchers Prepare Master’s Students to Work with Children with Developmental Disabilities
Many children with developmental disabilities, such as autism, have high-intensity behavioral needs, meaning they require a wide-ranging support system of people appropriately trained to work together to address their needs. Nearly 400,000 students in Connecticut have special health care needs. In the past decade, the prevalence of children with developmental disabilities has increased by 17% […]
November 12, 2020 | Anna Zarra Aldrich '20 (CLAS), Office of the Vice President for Research
UConn, DIANT Pharma Licenses Continuous Manufacturing Nanoparticle System
UConn researchers have licensed a continuous manufacturing system for nanoparticulate drug delivery systems in support of commercialization.
November 11, 2020 | Anna Zarra Aldrich '20 (CLAS), Office of the Vice President for Research